Showing results (61-70 of 279) with videos related to

Sort By:
Pageof 28
Diabetes Care|August 28, 2012
The use of metformin and the incidence of lung cancer in patients with type 2 diabetesBrielan B Smiechowski, Laurent Azoulay, Hui Yin, et al.
Hospital Pharmacy|November 21, 2024
Pharmacist-led Transitions of Care: A Cohort Study on Admission Medication History Factors and Adjustments to the Discharge Medication ListTatianna N Pollak, Colleen M Renier, John P Curley, et al.
The Biochemical Journal|July 15, 2014
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondriaHannah R Bridges, Andrew J Y Jones, Michael N Pollak, et al.
British Journal of Cancer|June 3, 2010
Insulin-like growth factors and risk of kidney cancer in menJ M Major, M N Pollak, K Snyder, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 12, 2002
Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrationsMichelle D Holmes, Michael N Pollak, Walter C Willett, et al.
American Journal of Epidemiology|August 26, 2003
Serum insulin-like growth factor I and subsequent risk of colorectal cancer among Japanese-American menAbraham M Y Nomura, Grant N Stemmermann, James Lee, et al.
The Journal of the American Academy of Orthopaedic Surgeons|August 7, 2012
Updates on disaster preparedness and progress in disaster reliefAndrew N Pollak, Christopher T Born, Robin N Kamal, et al.
Cancer Causes & Control : CCC|April 3, 2013
Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancerJonathan Assayag, Hui Yin, Serge Benayoun, et al.
Neuroepidemiology|March 4, 2010
Fasting plasma insulin, C-peptide and cognitive change in older men without diabetes: results from the Physicians' Health Study IIOlivia I Okereke, Tobias Kurth, Michael N Pollak, et al.
Pageof 28